SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Is the EQ–5D fit for purpose in mental health?
2 references·4 citing·25 second hop
Is the EQ–5D fit for purpose in mental health? (2010)Is the EQ–5D fit for purpose in mental he…Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance (2006)Guidance for industry: patien…EuroQol: the current state of play (1996)EuroQol: the current state of…Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D (2014)Using generic preference-base…Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures (2014)Assessing outcomes for cost-u…Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UK (2013)Development of a Disease-Spec…How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review (2011)How Valid and Responsive Are …Health Measurement Scales: A Practical Guide to Their Development and Use (1989)SF-36 physical and mental health summary scales : a user's manual (1994)A 12-Item Short-Form Health Survey (1996)A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders (2011)What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews (2017)A utility maximization model for evaluation of health care programs. (1972)The Effect of Adding a Cognitive Dimension to the EuroQol Multiattribute Health-Status Classification System (1999)Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)EQ-5D in skin conditions: an assessment of validity and responsiveness (2014)A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values (2015)An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study (2017)EuroQol - a new facility for the measurement of health-related quality of life (1990)EQ-SD: a measure of health status from the EuroQol Group (2001)The Hospital Anxiety and Depression Scale (1983)The validity of the Hospital Anxiety and Depression Scale (2002)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study) (2015)A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults (2016)Cost Utility Analysis of Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder: Randomized Controlled Trial (2024)The estimation of a preference-based measure of health from the SF-36 (2002)Screening for Serious Mental Illness in the General Population (2003)Health-related quality of life and economic burden of prurigo nodularis (2021)Development and Validation of Patient-Reported Outcome Measures for Sleep Disturbance and Sleep-Related Impairments (2010)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)
this work references cited by second hop

References

  • 1996EuroQol: the current state of play5,812 cited
  • 2006Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance2,855 cited

Cited by

  • 2011How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review141 cited
  • 2014Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D134 cited
  • 2013Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UK106 cited
  • 2014Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures78 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work